Renaissance Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
Other funds holding CAH
Renaissance Group's CAH Position: Q2 2026 in Review
Renaissance Group reduced its Cardinal Health (CAH) stake by 6.9% in Q2 2026, selling an estimated $2.48M and leaving 162,184 shares worth $38.5M. The position accounts for 1.56% of the portfolio, ranked #14.
Renaissance Group first reported a position in CAH in Q3 2015 and has held it in 17 quarters since. The position peaked at $39.1M in Q1 2025. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Renaissance Group held 162,184 shares of Cardinal Health worth $38.5M as of Q2 2026.
- Renaissance Group sold 11,931 Cardinal Health shares in Q2 2026, an estimated $2.48M.
- Cardinal Health made up 1.56% of Renaissance Group's portfolio in Q2 2026, its #14 holding.
- Renaissance Group first reported a position in Cardinal Health in Q3 2015 and has held it in 17 quarters since.
- Renaissance Group's Cardinal Health position peaked at $39.1M in Q1 2025.
- 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.